Vinay Prasad, the Director of the FDA’s Center for Biologics Evaluation and Research, has been outspoken in his criticism of Covid vaccines. He has also minimized the effectiveness of mask-wearing and compared Covid public health measures to Nazi Germany. After being temporarily removed from his position in July due to social media pressure, he returned before mid-August.

In May, Prasad and FDA Commissioner Martin A. Makary published a piece urging limits on Covid vaccination, claiming that U.S. policies often assume the public’s limited understanding of age- and risk-based guidelines. However, vaccination and mask-wearing remain crucial for reducing Covid infections and preventing Long Covid.

The 2025-2026 Covid vaccine rollout has been approved for various age groups with pre-existing conditions, though eligibility rules differ by state. Some states allow self-attestation of health risks like depression, while others require a doctor’s note.

Since his return, Prasad has received special privileges. According to reports, he has spent around three days every two weeks working at the FDA’s Maryland headquarters, despite concerns about his lengthy commute from California. The agency has been covering travel costs, though Prasad declined to comment, and the HHS did not address his absence from the office.

While remote work can be beneficial for many, critics highlight the irony that Prasad, avoiding the office, can work from home while many federal employees are compelled to return, often risking Covid exposure. This discrepancy has drawn scrutiny, especially as healthcare workers face increased challenges and stress, and Prasad had previously criticized telecommuting on social media.